NCT02501954View on ClinicalTrials.gov

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage IIIA Uterine Corpus CancerStage IIIB Uterine Corpus CancerStage IIIC Uterine Corpus CancerStage IVA Uterine Corpus Cancer
Interventions
DRUG

Cisplatin

Given IV

DRUG

Carboplatin

Given IV

DRUG

Paclitaxel

Given IV

RADIATION

Radiation Therapy

Undergo Radiation Therapy

Trial Locations (7)

12208

Women's Cancer Care Associates, LLC, Albany

21204

Greater Baltimore Medical Center, Baltimore

43210

The Ohio State University, Columbus

49684

Munson Health Care, Traverse City

54601

Gunderson Lutheran Medical Foundation, La Crosse

07960

Atlantic Health, Morristown

H2L4M1

CHUM Hopital Notre-Dame, Montreal

All Listed Sponsors
lead

Women's Cancer Care Associates, LLC

OTHER

NCT02501954 - Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol | Biotech Hunter | Biotech Hunter